Spectrum SPB · NYSE
$78.97 +0.08% (+$0.06)
Summary
63 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 30% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $326.4M in the last fiscal year, 18% of its market value.
- Out of every 100 USD of revenue, 10 USD is left as free cash.
What to watch
- Revenue fell by 3.6% a year over the last 3 years.
- Out of every 100 USD of revenue, only 2.8 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 23.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 1.4% a year over 5 years. Over the last 3 years it fell by 3.6% a year. For the next fiscal year analysts expect revenue to grow by 1.9%. Earnings per share grew by 30% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 60 USD
- Research and development 0.4 USD
- Sales and administration 31 USD
- Taxes and other 5.5 USD
- Net profit 2.8 USD
Net profit, industry median (Household & Personal Products) 9.0 USD
Out of every 100 USD of revenue, 2.8 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 2.38%
- Paid out of profit
- 55%
- Raised in a row
- 2 years
You receive $1.88 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 14
- Hold 7
- Sell 0
Today's price within the analysts' price targets
The average target of $97.6 is 24% above today's price. 67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Home And Personal Care 41%
- Global Pet Supplies 39%
- Home And Garden Business 20%
By region
- UNITED STATES 56%
- EMEA 31%
- Latin America 7.6%
- Asia Pacific 3.3%
- North America, Excluding United States 1.9%
Home And Personal Care brings in 41% of revenue.
Segments in detail